Fiscal

General Finance Corporation Reports Second Quarter Results For Fiscal Year 2021

3 weeks ago Amanda T. Noriega

PASADENA, Calif., Feb. 08, 2021 (GLOBE NEWSWIRE) — General Finance Corporation (NASDAQ: GFN), a leading specialty rental services company offering portable storage, modular space and liquid containment solutions in North America and in the Asia-Pacific region of Australia and New Zealand (the “Company”), today announced its consolidated financial results for the second quarter and six months (“YTD”) ended December 31, 2020.

Second Quarter 2021 Highlights

  • Rental revenues from our core non-liquid containment products in North America increased by 9% from the second quarter of fiscal year 2020.

  • Leasing revenues were $58.4 million, compared to $60.8 million for the second quarter of fiscal year 2020.

  • Leasing revenues, excluding the oil and gas sector, increased by 5% in North America and by 4% in the Asia-Pacific from the second quarter of fiscal year 2020.

  • Leasing revenues comprised 66% of total non-manufacturing revenues versus 67% for the second quarter of fiscal year 2020.
… Read More

Ubiquiti Inc. Reports Second Quarter Fiscal 2021 Financial Results

3 weeks ago Amanda T. Noriega

NEW YORK–(BUSINESS WIRE)–Feb 5, 2021–

Ubiquiti Inc. (NYSE: UI) (“Ubiquiti” or the “Company”) today announced results for the second quarter fiscal 2021, ended December 31, 2020.

Second Quarter Fiscal 2021 Financial Summary

  • Revenues of $479.4 million, increasing 55.5% year-over-year

  • GAAP diluted EPS of $2.54, increasing 92.4% year-over-year

  • Non-GAAP diluted EPS of $2.53, increasing 80.7% year-over-year

Additional Financial Highlights

  • Repurchased 309,133 shares of common stock at an average price of $178.11 per share during the quarter.

  • The Company’s Board of Directors declared a $0.40 per share cash dividend payable on February 22, 2021 to shareholders of record at the close of business on February 16, 2021.

Financial Highlights ($, in millions, except per share data)







Income statement highlights

 

F2Q21

 

F1Q21

 

F2Q20

Revenues

 

479.4

 

473.5

 

308.3

Service Provider Technology

 

149.9

 

157.5

 

97.7

Enterprise Technology

 

329.6

 

316.1

 

210.6

Gross profit

 

230.7

 

228.1

 

145.1


Gross Profit (%)

 


48.1%

 


48.2%

 


47.1%

Total Operating Expenses

 

39.9

… Read More

Telenav Reports Second Quarter Fiscal 2021 Financial Results

3 weeks ago Amanda T. Noriega

SANTA CLARA, Calif.–(BUSINESS WIRE)–Telenav®, Inc. (NASDAQ:TNAV), a leading provider of connected-car and location-based services, today released its financial results for the second fiscal quarter ended Dec. 31, 2020. In light of the previously announced proposed acquisition of Telenav by V99, Inc., Telenav will not host a conference call to discuss these financial results or provide outlook regarding future operating performance or conditions.

Financial Highlights for the Second Quarter Ended Dec. 31, 2020

  • Total revenue for the second quarter of fiscal 2021 was $65.9 million, compared with $73.9 million in the second quarter of fiscal 2020.
  • Services revenue for the second quarter of fiscal 2021 was $12.4 million, compared with $12.3 million in the second quarter of fiscal 2020.
  • GAAP gross profit for the second quarter of fiscal 2021 was $27.7 million, compared with $40.2 million in the second quarter of fiscal 2020.
  • Billings, a non-GAAP measure, for the
… Read More

Twist Bioscience Reports First Quarter Fiscal 2021 Financial Results

3 weeks ago Amanda T. Noriega

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Feb 4, 2021–

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today reported financial results and business highlights for the first quarter of fiscal 2021 ended December 31, 2020.

“We reported a strong quarter both for orders and revenue, building a solid foundation for fiscal 2021,” said Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience. “We see early evidence that our investment in synbio products for our pharmaceutical and biotech customers is beginning to gain traction, and for our NGS tools business, our liquid biopsy customers continue to drive revenue growth. Both our biopharma and DNA data storage teams made progress in advancing technologies, and we strengthened our balance sheet with $324 million through a recent equity offering.

“Looking ahead, we expect continued growth and diversification of our revenue stream

… Read More

Bill.com Reports Second Quarter Fiscal 2021 Financial Results

3 weeks ago Amanda T. Noriega

SAN JOSE, Calif.–(BUSINESS WIRE)–Feb 4, 2021–

Bill.com (NYSE: BILL), a leading provider of cloud-based software that simplifies, digitizes, and automates complex back-office financial operations for small and midsize businesses (SMBs), today announced financial results for the second fiscal quarter ended December 31, 2020.

“We delivered strong financial results and record payment volume growth driven by robust demand for our platform and its expanded payment offerings,” said René Lacerte, Bill.com CEO. “Adoption and usage continues to strengthen in this new remote environment as we are effectively guiding companies on their digital transformation path. Our offering has become a mission-critical tool for many small and midsize businesses. The increasing scale of our platform purpose-built for SMBs is automating financial operations facilitating over ten billion dollars of B2B payments each month.”

Financial Highlights for the Second Quarter of Fiscal 2021

  • Total revenue was $54.0 million, an increase of 38% from the second quarter
… Read More

Twist Bioscience Reports First Quarter Fiscal 2021 Financial Results | Ap

3 weeks ago Amanda T. Noriega

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Feb 4, 2021–

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today reported financial results and business highlights for the first quarter of fiscal 2021 ended December 31, 2020.

“We reported a strong quarter both for orders and revenue, building a solid foundation for fiscal 2021,” said Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience. “We see early evidence that our investment in synbio products for our pharmaceutical and biotech customers is beginning to gain traction, and for our NGS tools business, our liquid biopsy customers continue to drive revenue growth. Both our biopharma and DNA data storage teams made progress in advancing technologies, and we strengthened our balance sheet with $324 million through a recent equity offering.

“Looking ahead, we expect continued growth and diversification of our revenue stream

… Read More

You may have missed

Create Your Personal Website

2 days ago Amanda T. Noriega

Improve Attain With Display Advert Banners And Extra

4 days ago Amanda T. Noriega

Why Is SEARCH ENGINE OPTIMISATION Advertising and marketing Important For Your Business

7 days ago Amanda T. Noriega

The True SEARCH ENGINE OPTIMISATION Price

1 week ago Amanda T. Noriega

High-end Specifications And Features of Realme 5 Pro Smartphones

2 weeks ago Amanda T. Noriega